Philip Chung
About Philip Chung
Philip Chung is a Sr Principal Process Engineer in Cell Therapy Process Engineering at Bristol Myers Squibb, with extensive experience in pilot plant operations and technical specialization from his 17-year tenure at Genentech.
Current Role at Bristol Myers Squibb
Philip Chung is currently employed as a Senior Principal Process Engineer in Cell Therapy Process Engineering within the Global MSAT team at Bristol Myers Squibb. He has held this role since December 2020 and operates out of the Greater Seattle Area. In this position, he focuses on the development and optimization of cell therapy processes, contributing to advancements in global manufacturing science and technology.
Past Experience at Genentech
Philip Chung accumulated extensive experience during his 17-year tenure at Genentech. He held numerous roles, starting as a Senior Bioprocess Technician in Cell Culture Manufacturing from 2000 to 2003 in Vacaville, CA. He later worked in various capacities within the Purification & Drug Product Pilot Plant in South San Francisco, including roles as Pilot Plant Technical Specialist and Manager, from 2004 to 2020. He contributed significantly to pilot plant operations, technical specialization, and quality development.
Research Positions and Early Career
Before joining the pharmaceutical industry, Philip Chung worked in academic and scientific research positions. From 1997 to 2000, he served as a Research Assistant at the California Academy of Sciences in San Francisco. He then joined the University of California, San Francisco, where he worked as a Senior Research Assistant for one year from 1999 to 2000. His early career was marked by contributions to scientific research and data analysis.
Education and Academic Background
Philip Chung holds multiple degrees in scientific disciplines. He completed his Bachelor of Science in Physiology, General, and another Bachelor of Science in Biological/Biosystems Engineering at San Francisco State University. Additionally, he studied at Rutgers University and earned a Bachelor of Science over a five-year period from 2003 to 2008. This educational background provided him with a strong foundation in both physiology and engineering, fueling his career in process engineering.
Expertise in Cell Therapy Process Engineering
Philip Chung has developed significant expertise in cell therapy process engineering, particularly in the area of global manufacturing science and technology (MSAT). His role at Bristol Myers Squibb involves the optimization and development of cell therapy processes, leveraging his extensive background in pilot plant operations and technical specialization gained during his time at Genentech. His work contributes to the advancement of manufacturing processes for cell therapies on a global scale.